Brief: Tianjin Development Says FY Net Profit Attributable Of Tianjin Lisheng Pharmaceutical Is RMB8.6 Million
March 24 (Reuters) - Tianjin Lisheng Pharmaceutical Co Ltd
002393.SZ :
* FY NET PROFIT ATTRIBUTABLE OF TIANJIN LISHENG
PHARMACEUTICAL
RMB8.6 MILLION VERSUS RMB188.1 MILLION
* FY TOTAL OPERATING INCOME FOR TIANJIN LISHENG
PHARMACEUTICAL
RMB1.14 BILLION VERSUS RMB1.62 BILLION
* LISHENG PHARMACEUTICAL PROPOSED CASH DIVIDEND OF RMB1.00
(TAX
INCLUSIVE) FOR EVERY 10 SHARES
Source text for Eikon: urn:newsml:reuters.com:*:nHKS6TvBFX
Further company coverage: 002393.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln